I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Low number of KIR ligands in lymphoma patients favors a goo..:
Makanga, Dhon
;
Jullien, Maxime
;
David, Gaëlle
...
info:eu-repo/semantics/altIdentifier/doi/10.1080/2162402x.2021.1936392. , 2021
Link:
https://www.hal.inserm.fr/inserm-03287975
RT Journal T1 <Title>Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftccsdartic:oai:HAL:inserm-03287975v1&Exemplar=1&LAN=DE A1 Makanga, Dhon A1 Jullien, Maxime A1 David, Gaëlle A1 Legrand, Nolwenn A1 Willem, Catherine A1 Dubreuil, Léa A1 Walencik, Alexandre A1 Touzeau, Cyrille A1 Gastinne, Thomas A1 Tessoulin, Benoit A1 Le Gouill, Steven A1 Mahé, Béatrice A1 Gagne, Katia A1 Chevallier, Patrice A1 Clemenceau, Béatrice A1 Retière, Christelle PB HAL CCSD; Taylor & Francis YR 2021 K1 cd16 K1 adcc K1 KIR K1 hla K1 nk cells K1 non hodgkin lymphoma K1 rituximab K1 [SDV.CAN]Life Sciences [q-bio]/Cancer JF info:eu-repo/semantics/altIdentifier/doi/10.1080/2162402x.2021.1936392 LK http://dx.doi.org/https://www.hal.inserm.fr/inserm-03287975 DO https://www.hal.inserm.fr/inserm-03287975 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
